Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Inserm U953 (Epidemiological research unit on perinatal health and women's and children's health) Paris, France | UNKNOWN |
| University Hospital, Angers | OTHER_GOV |
| URC-CIC Paris Descartes Necker Cochin | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to identify what factors -either individual or related to the type of management received- influence the maternal outcomes in pregnant women at high risk for placenta accreta i.e , women with placenta praevia and previous caesarean.
This population-based study conducted in 8 French regions will also provide valid estimation of the incidence of placenta accreta among all parturients and among "at risk "women. Finally, a psychological evaluation of these women up to 1 year after delivery will provide information on the impact of these conditions on women, beyond somatic complications.
Background: No population-based study has assessed the prevalence of placenta accreta, the predictive value of prenatal diagnostic examinations, the maternal morbidity associated with its management, or its psychological effects. Moreover the technical resources necessary for the safest delivery of women at risk have not been clearly identified.
Objectives: The primary objectives are to identify individual risk factors for maternal morbidity, as well as risk factors related to types of management and healthcare facilities for postpartum hemorrhage (PPH). Secondary objectives are to 1) determine the prevalence of placenta accreta among women at risk; 2) assess the predictive value of ultrasound and MRI for the diagnosis of placenta accreta in this population; 3) evaluate psychological impact and physical complications; 4) report maternal physical complications during the year after delivery.
Design: Population-based prospective observational study of pregnant women with a placenta inserted at a uterine scar Setting; A total of 166 centers in 8 French regions, with 260,000 deliveries annually.
Methods: We expect to include 570 women at risk of placenta accreta in two years, of whom approximately 100 (20%) will have placenta accreta.
Main outcome measures: The primary outcome measure is severe maternal hemorrhage; secondary outcome measures are maternal morbidity and deaths, predictive value of ultrasound and MRI, and psychological evaluations at 1, 6 and 12 months after delivery.
Conclusion: This study will be the first prospective population-based study to include women at risk of placenta accreta and to investigate incidence, prenatal detection, type of management, morbidity and maternal psychological consequences.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| women at high risk of placenta accreta | Parturient women with placenta praevia and at least one previous caesarean delivery |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Severe postpartum hemorrhage | Severe hemorrhage defined by a hemorrhage with transfusion of at least four red blood cell units. | up to 7 days post delivery |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of accreta or percreta placenta overall and in women with previous caesarean section and placenta praevia | Number of women with placenta accreta divided 1)by the number of parturient women, and 2) by the number of women with previous caesarean section and placenta praevia | At delivery |
| Predictive value of prenatal ultrasound and MRI for the diagnosis of placenta accreta in women with previous caesarean section and placenta praevia |
Not provided
Inclusion Criteria:
Every woman:
Exclusion Criteria:
Every woman:
Not provided
Not provided
Not provided
Women delivering in maternity units of 8 French regions.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gilles Kayem, MD, PhD | Louis Mourier University Hospital (APHP), department of gynaecology and obstetrics, Colombes, France | Principal Investigator |
| Loic Sentilhes, MD, PhD | Angers University Hospital, department of gynaecology and obstetrics, France | Principal Investigator |
| Catherine Deneux-Tharaux, MD, PhD | INSERM U953, Epidemiological research unit on perinatal health and children's and women's health, Paris, France | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Louis Mourier (APHP) | Colombes | 92700 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33393174 | Result | Kayem G, Seco A, Beucher G, Dupont C, Branger B, Crenn Hebert C, Huissoud C, Fresson J, Winer N, Langer B, Rozenberg P, Morel O, Bonnet MP, Perrotin F, Azria E, Carbillon L, Chiesa C, Raynal P, Rudigoz RC, Dreyfus M, Vendittelli F, Patrier S, Deneux-Tharaux C, Sentilhes L. Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study. BJOG. 2021 Sep;128(10):1646-1655. doi: 10.1111/1471-0528.16647. Epub 2021 Feb 3. | |
| 37226308 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010921 | Placenta Accreta |
| D010923 | Placenta Previa |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Sensitivity, specificity and positive and negative predictive values. |
| at delivery |
| severe maternal morbidity | haemorrhage, infection, intraoperative and postoperative complications, thromboembolic complications. | up to 6 months post-delivery |
| Psychological impact | All the women will receive several validated auto-questionnaires (postpartum depression, anxiety, post-traumatic stress). | at 1 year post-delivery |
| Psychological impact | All the women will receive several validated auto-questionnaires (postpartum depression, anxiety, post-traumatic stress) | at 1 month post-delivery |
| Psychological impact | All the women will receive several validated auto-questionnaires (postpartum depression, anxiety, post-traumatic stress) | at 6 month post-delivery |
| Result |
| Pinton A, Deneux-Tharaux C, Seco A, Sentilhes L, Kayem G; PACCRETA Study Group. Incidence and risk factors for severe postpartum haemorrhage in women with anterior low-lying or praevia placenta and prior caesarean: Prospective population-based study. BJOG. 2023 Dec;130(13):1653-1661. doi: 10.1111/1471-0528.17554. Epub 2023 May 24. |
| 35772474 | Result | Sentilhes L, Seco A, Kayem G, Deneux-Tharaux C. Postdischarge outcomes of readmitted women included in the PACCRETA study. Am J Obstet Gynecol. 2022 Nov;227(5):795-798. doi: 10.1016/j.ajog.2022.06.042. Epub 2022 Jun 27. No abstract available. |
| 34914894 | Result | Sentilhes L, Seco A, Azria E, Beucher G, Bonnet MP, Branger B, Carbillon L, Chiesa C, Crenn-Hebert C, Dreyfus M, Dupont C, Fresson J, Huissoud C, Langer B, Morel O, Patrier S, Perrotin F, Raynal P, Rozenberg P, Rudigoz RC, Vendittelli F, Winer N, Deneux-Tharaux C, Kayem G; PACCRETA Study Group. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022 Jun;226(6):839.e1-839.e24. doi: 10.1016/j.ajog.2021.12.013. Epub 2021 Dec 14. |
| D010922 | Placenta Diseases |